"I want you to think about ways we can help blow up and make the market more innovative."
"I think we have to take a look at the Stark Act."
"Well, if you have language I would be very interested in it because I would like to blow up the way we do the reimbursements so we can blow up the medical system and make costs come down."
"While we had criminal conduct by NECC, we also had timid lawyers at the FDA."
"And I disagree, just based on the debate that we had when we were doing this a number of years ago in 2013, because we anticipated there would be continued office use."
"As Ms. DeGette said, there has got to be a balance."
"And I would just ask, in relationship to 503A, because we were talking about it earlier, if that didn't contemplate office use, then why has FDA allowed it up until this point in time?"
"This is why the Academy is supporting policy that ensures access to drugs for office space use, such H.R. 2871, the Preserving Patient Access to Compounded Medications Act, introduced by Congressman M..."
"I think sometimes we are talking at cross-purposes because I don't think any of us want to see somebody like NECC coming back."
"We have to try to find that balance, because we have situations that, in all fairness, I wasn't aware that one of the solutions to resolve the problem was that we were going to have folks going and pi..."
"Commissioner Gottlieb, of all the folks that we have dealt with at that level, is probably the most responsive that the committee has found."
"If you look at the timetable there on their chart... you told them you were about to do it, and 4 days later, they were, like, 'OK, OK, we'll do it voluntarily.'"